Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Jones, A. Burks, C. Dupont (2014)
State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous.The Journal of allergy and clinical immunology, 133 2
M. Jutel (2014)
Allergen-Specific Immunotherapy in AsthmaCurrent Treatment Options in Allergy, 1
RE O’Hehir, LM Gardner, MP Leon, BJ Hales, M Biondo, JA Douglass (2009)
House dust mite sublingual immunotherapyAm J Respir Crit Care Med, 180
S. Durham (2011)
Sustained effects of grass pollen AITAllergy, 66
M. Fernández-Rivas, S. Fernández, J. Nadal, M. Durana, B. García, E. González-Mancebo, S. Martín, D. Barber, P. Rico, A. Tabar (2009)
Randomized double‐blind, placebo‐controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extractAllergy, 64
G. Lal, J. Bromberg (2009)
Epigenetic mechanisms of regulation of Foxp3 expression.Blood, 114 18
P. Bégin, R. Chinthrajah, Kari Nadeau (2014)
Oral immunotherapy for the treatment of food allergyHuman Vaccines & Immunotherapeutics, 10
L. Mascarell, Vincent Lombardi, Aline Zimmer, A. Louise, S. Tourdot, L. Overtvelt, P. Moingeon (2009)
Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cellsClinical & Experimental Allergy, 39
M. Bonvalet, H. Moussu, E. Wambre, C. Ricarte, S. Horiot, A. Rimaniol, W. Kwok, F. Horak, O. Beaumont, V. Baron-Bodo, P. Moingeon (2012)
Allergen‐specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapyClinical & Experimental Allergy, 42
C. Keet, P. Frischmeyer-Guerrerio, A. Thyagarajan, J. Schroeder, R. Hamilton, S. Boden, Pamela Steele, S. Driggers, A. Burks, R. Wood (2012)
The safety and efficacy of sublingual and oral immunotherapy for milk allergy.The Journal of allergy and clinical immunology, 129 2
D. Miranda, D. Silva, J.F.C. Fernandes, Meimei Queirós, Hamilton Chiba, L. Ynoue, R. Resende, J. Pena, S. Sung, G. Segundo, E. Taketomi (2011)
Serum and Salivary IgE, IgA, and IgG4 Antibodies to Dermatophagoides pteronyssinus and Its Major Allergens, Der p1 and Der p2, in Allergic and Nonallergic ChildrenClinical and Developmental Immunology, 2011
V. Baron-Bodo, S. Horiot, Aurélie Lautrette, H. Chabre, A. Drucbert, P. Danzé, H. Sénéchal, Gabriel Peltre, S. Galvain, R. Zeldin, Friedrich Horak, P. Moingeon (2013)
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapyClinical & Experimental Allergy, 43
C. Pereira, B. Bartolomé, J. Asturias, I. Ibarrola, B. Tavares, G. Loureiro, D. Machado, C. Chieira (2009)
Specific sublingual immunotherapy with peach LTP (Pru p 3). One year treatment: a case reportCases Journal, 2
G. Ciprandi, D. Fenoglio, I. Cirillo, A. Vizzaccaro, A. Ferrera, M. Tosca, F. Puppo (2005)
Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 95 1
T. Fujimura, S. Yonekura, Yuriko Taniguchi, S. Horiguchi, A. Saito, H. Yasueda, T. Nakayama, T. Takemori, M. Taniguchi, M. Sakaguchi, Y. Okamoto (2010)
The Induced Regulatory T Cell Level, Defined as the Proportion of IL-10+Foxp3+ Cells among CD25+CD4+ Leukocytes, Is a Potential Therapeutic Biomarker for Sublingual Immunotherapy: A Preliminary ReportInternational Archives of Allergy and Immunology, 153
R. Wood, A. Togias, J. Wildfire, C. Visness, E. Matsui, R. Gruchalla, G. Hershey, A. Liu, G. O'Connor, J. Pongracic, E. Zoratti, F. Little, M. Granada, Suzanne Kennedy, S. Durham, M. Shamji, W. Busse (2014)
Development of cockroach immunotherapy by the Inner-City Asthma Consortium.The Journal of allergy and clinical immunology, 133 3
K. Yamanaka, A. Yuta, M. Kakeda, R. Sasaki, H. Kitagawa, E. Gabazza, K. Okubo, I. Kurokawa, H. Mizutani (2009)
Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis.The Journal of allergy and clinical immunology, 124 4
G. Guida, M. Boita, T. Scirelli, L. Bommarito, E. Heffler, I. Badiu, G. Bellone, S. Mietta, G. Mistrello, G. Rolla (2012)
Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy.Allergy and asthma proceedings, 33 5
M. Kulis, Katie Saba, Edwin Kim, J. Bird, N. Kamilaris, B. Vickery, H. Staats, A. Burks (2012)
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.The Journal of allergy and clinical immunology, 129 4
David Skoner, D. Gentile, R. Bush, M. Fasano, A. McLaughlin, R. Esch (2010)
Rhinitis , sinusitis , and upper airway disease Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen
Gary Linkov, E. Toskala (2014)
Sublingual immunotherapy: what we can learn from the European experienceCurrent Opinion in Otolaryngology & Head and Neck Surgery, 22
S. Radulovic, D. Wilson, M. Calderón, S. Durham (2011)
Systematic reviews of sublingual immunotherapy (SLIT)Allergy, 66
G. Scadding, M. Shamji, M. Jacobson, D. Lee, Duncan Wilson, M. Lima, L. Pitkin, C. Pilette, K. Nouri-Aria, S. Durham (2010)
Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3‐expressing cells and elevated allergen‐specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E‐facilitated allergen binding to B cellsClinical & Experimental Allergy, 40
Anouk Gloudemans, B. Lambrecht, H. Smits (2013)
Potential of Immunoglobulin A to Prevent Allergic AsthmaClinical and Developmental Immunology, 2013
J. Francis, S. Till, S. Durham (2003)
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.The Journal of allergy and clinical immunology, 111 6
Edwin Kim, J. Bird, M. Kulis, S. Laubach, W. Shreffler, L. Pons, Pamela Steele, J. Kamilaris, B. Vickery, A. Burks (2011)
Evidence of Desensitization by Sublingual Immunotherapy in Peanut-Allergic ChildrenThe Journal of Allergy and Clinical Immunology, 127
A. Eifan, A. Eifan, T. Akkoç, A. Yıldız, S. Keleş, C. Ozdemir, N. Bahceciler, I. Barlan (2010)
Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trialClinical & Experimental Allergy, 40
R. O'Hehir, L. Gardner, M. Leon, B. Hales, M. Biondo, J. Douglass, J. Rolland, A. Sandrini (2009)
House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells.American journal of respiratory and critical care medicine, 180 10
S. Durham, William Yang, M. Pedersen, N. Johansen, S. Rak (2006)
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.The Journal of allergy and clinical immunology, 117 4
L. Yel (2010)
Selective IgA DeficiencyJournal of Clinical Immunology, 30
H. Nelson (2013)
Sublingual immunotherapy: the U.S. experienceCurrent Opinion in Allergy and Clinical Immunology, 13
N. Novak, E. Gros, T. Bieber, J. Allam (2010)
Human skin and oral mucosal dendritic cells as ‘good guys’ and ‘bad guys’ in allergic immune responsesClinical & Experimental Immunology, 161
J. Allam, G. Stojanovski, N. Friedrichs, Wenming Peng, T. Bieber, J. Wenzel, N. Novak (2008)
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?Allergy, 63
Georg Wieczorek, A. Asemissen, F. Model, Ivana Turbachova, S. Floess, Volker Liebenberg, U. Baron, D. Stauch, K. Kotsch, J. Pratschke, A. Hamann, C. Loddenkemper, H. Stein, H. Volk, U. Hoffmüller, A. Grützkau, A. Mustea, J. Huehn, C. Scheibenbogen, S. Olek (2009)
Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.Cancer research, 69 2
Hagen Ott, Jochen Sieber, Randolf Brehler, Regina Fölster-Holst, Alexander Kapp, Ludger Klimek, O. Pfaar, H. Merk (2009)
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT studyAllergy, 64
R. Swamy, N. Reshamwala, T. Hunter, S. Vissamsetti, C. Santos, F. Baroody, P. Hwang, Elisabeth Hoyte, Marco Garcia, K. Nadeau (2012)
Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.The Journal of allergy and clinical immunology, 130 1
O. Cavkaytar, C. Akdis, M. Akdiş (2014)
Modulation of immune responses by immunotherapy in allergic diseases.Current opinion in pharmacology, 17
Y. Nagai, D. Shiraishi, Y. Tanaka, Y. Nagasawa, S. Ohwada, H. Shimauchi, H. Aso, Y. Endo, S. Sugawara (2015)
Transportation of sublingual antigens across sublingual ductal epithelial cells to the ductal antigen‐presenting cells in miceClinical & Experimental Allergy, 45
H. Fujita, M. Soyka, M. Akdiş, C. Akdis (2012)
Mechanisms of allergen-specific immunotherapyClinical and Translational Allergy, 2
S. Burastero, G. Mistrello, P. Falagiani, C. Paolucci, D. Breda, D. Roncarolo, S. Zanotta, Giorgio Monasterolo, R. Rossi (2008)
Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 100 4
Aleena Syed, Marco Garcia, S. Lyu, Robert Bucayu, Arunima Kohli, S. Ishida, J. Berglund, M. Tsai, H. Maecker, G. O’Riordan, S. Galli, K. Nadeau (2014)
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).The Journal of allergy and clinical immunology, 133 2
A. Zimmer, J. Bouley, M. Mignon, E. Pliquet, S. Horiot, M. Turfkruyer, V. Baron-Bodo, F. Horak, E. Nony, A. Louise, H. Moussu, L. Mascarell, P. Moingeon (2012)
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy.The Journal of allergy and clinical immunology, 129 4
U. Wahn, L. Klimek, A. Płoszczuk, T. Adelt, B. Sandner, E. Trębas-Pietraś, P. Eberle, A. Bufe (2012)
High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.The Journal of allergy and clinical immunology, 130 4
Sakura Sato, N. Yanagida, K. Ogura, T. Imai, Tomohiro Utsunomiya, K. Iikura, M. Goto, Tomoyuki Asaumi, Yu Okada, Yumi Koike, Akinori Syukuya, M. Ebisawa (2014)
Clinical Studies in Oral Allergen-Specific Immunotherapy: Differences among AllergensInternational Archives of Allergy and Immunology, 164
D Skoner, D Gentile, R Bush, MB Fasano, A McLaughlin, RE Esch (2010)
Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollenJ Allergy Clin Immunol, 125
P. Creticos, R. Esch, P. Couroux, D. Gentile, P. D'Angelo, Brad Whitlow, M. Alexander, T. Coyne (2014)
Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.The Journal of allergy and clinical immunology, 133 3
N. Bahceciler, N. Galip (2012)
Comparing subcutaneous and sublingual ımmunotherapy: what do we know?Current Opinion in Allergy and Clinical Immunology, 12
F. Angelini, V. Pacciani, S. Corrente, R. Silenzi, A. Pede, A. Polito, C. Riccardi, S. Cesare, M. Yammine, P. Rossi, V. Moschese, L. Chini (2011)
Dendritic cells modifi cation during sublingual immunotherapy in children with allergic symptoms to house dust mitesWorld Journal of Pediatrics, 7
C. Akdis, T. Blesken, M. Akdiş, B. Wüthrich, K. Blaser (1998)
Role of interleukin 10 in specific immunotherapy.The Journal of clinical investigation, 102 1
J. Dretzke, A. Meadows, N. Novielli, A. Huissoon, A. Fry-Smith, C. Meads (2013)
Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.The Journal of allergy and clinical immunology, 131 5
Meimei Queirós, D. Silva, I. Siman, L. Ynoue, N. Araújo, F. Pereira, K. Almeida, J. Miranda, J. Pena, J. Cunha-Júnior, E. Taketomi (2013)
Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite‐allergic childrenPediatric Allergy and Immunology, 24
M. Makatsori, G. Scadding, C. Lombardo, G. Bisoffi, E. Ridolo, S. Durham, G. Senna (2014)
Dropouts in sublingual allergen immunotherapy trials – a systematic reviewAllergy, 69
A. Cerutti (2008)
The regulation of IgA class switchingNature Reviews Immunology, 8
Edwin Kim, J. Bird, M. Kulis, S. Laubach, L. Pons, W. Shreffler, Pamela Steele, J. Kamilaris, B. Vickery, A. Burks (2011)
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization.The Journal of allergy and clinical immunology, 127 3
J. Allam, P. Würtzen, M. Reinartz, J. Winter, S. Vrtala, Kuan-Wei Chen, R. Valenta, M. Wenghoefer, T. Appel, E. Gros, B. Niederhagen, T. Bieber, K. Lund, N. Novak (2010)
Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties.The Journal of allergy and clinical immunology, 126 3
Laurence Pellerin, Jennifer Jenks, P. Bégin, R. Bacchetta, K. Nadeau (2014)
Regulatory T cells and their roles in immune dysregulation and allergyImmunologic Research, 58
Pascal Demoly, Moises Calderon (2011)
Dosing and efficacy in specific immunotherapyAllergy, 66
N. Romani, B. Clausen, P. Stoitzner (2010)
Langerhans cells and more: langerin‐expressing dendritic cell subsets in the skinImmunological Reviews, 234
S. Sakaguchi, M. Miyara, C. Costantino, D. Hafler (2010)
FOXP3+ regulatory T cells in the human immune systemNature Reviews Immunology, 10
T. Moran, B. Vickery, A. Burks (2013)
Oral and sublingual immunotherapy for food allergy: current progress and future directions.Current opinion in immunology, 25 6
A. Suárez-Fueyo, T. Ramos, A. Galán, L. Jimeno, P. Wurtzen, A. Marín, C. Frutos, C. Blanco, A. Carrera, D. Barber, R. Varona (2014)
Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.The Journal of allergy and clinical immunology, 133 1
B. Bohle, T. Kinaciyan, M. Gerstmayr, A. Radakovics, B. Jahn-Schmid, C. Ebner (2007)
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.The Journal of allergy and clinical immunology, 120 3
K. Mutyambizi, C. Berger, R. Edelson (2009)
The balance between immunity and tolerance: The role of Langerhans cellsCellular and Molecular Life Sciences, 66
L. James, M. Shamji, S. Walker, Duncan Wilson, P. Wachholz, J. Francis, M. Jacobson, I. Kimber, S. Till, S. Durham (2011)
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.The Journal of allergy and clinical immunology, 127 2
Sublingual immunotherapy (SLIT) is a well-established allergen-specific immunotherapy and a safe and effective strategy to reorient inappropriate immune responses in allergic patients. SLIT takes advantage of the tolerogenic environment of the oral mucosa to promote tolerance to the allergen. Several clinical studies have investigated the complex interplay of innate and adaptive immune responses that SLIT exploits. The oral immune system is composed of tolerogenic dendritic cells that, following uptake of allergen during SLIT, support the differentiation of T helper cell type 1 (Th1) and the induction of IL-10-producing regulatory T cells. Following SLIT, allergic disease-promoting T helper cell type 2 (Th2) responses shift to a Th1 inflammatory response, and IL-10 and transforming growth factor (TGF)-β production by regulatory T cells and tolerogenic dendritic cells suppress allergen-specific T cell responses. These immune changes occur both in the sublingual mucosa and in the periphery of a patient following SLIT. SLIT also promotes the synthesis of allergen-specific IgG and IgA antibodies that block allergen-IgE complex formation and binding to inflammatory cells, thus encouraging an anti-inflammatory environment. Several of these revealing findings have also paved the way for the identification of biomarkers of the clinical efficacy of SLIT. This review presents the emerging elucidation of the immune mechanisms mediated by SLIT.
Current Allergy and Asthma Reports – Springer Journals
Published: Sep 7, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.